Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

If you have been staring at CRISPR Therapeutics stock lately, wondering whether it is time to buy, hold, or rethink your position, you are far from alone. Over the past week, the stock has surged 16.1 ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:CRSP), and it's something market players shouldn't ignore. Our tracking of public options records at ...

The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even pronatalists. But it is still deeply controversial.

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Het aandeel Crispr Therapeutics AG heeft een belangrijke mijlpaal bereikt met een 52-weeks hoogtepunt van $ 71,14, waarbij InvestingPro data een indrukwekkende stijging van 93,5% over de afgelopen zes ...